Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

Moderna Inc.'s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat.

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

The report, entitled Unlocking Operational Excellence in Fund Administration through AI, is based on insights from in-depth ...

Shares of FactSet Research Systems Inc. FDS rose 1.14% to $459.39 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6, ...

CBRE Group posted strong fourth-quarter earnings for 2024, surpassing analyst expectations and demonstrating solid segment performance.

AI is still a nascent part of Moody's business, but the early indicators point to success for company. That makes the stock a terrific opportunity to buy hand over fist. Investors with a long-run ...

FactSet’s private markets data strategy, the relationship between risk and performance on the buy side and fixed income track record ...

On a monthly basis, the CPI rose 0.5%, versus economists' forecast for a 0.3% increase, according to FactSet. That's the ...